MedPath

Intrathecal Atropine Versus Intravenous Ondasetron in Post Operative Nausea Due to Intrathecal Morphine

Not Applicable
Conditions
Perineal Surgery
Interventions
Registration Number
NCT05137288
Lead Sponsor
Sohag University
Brief Summary

To compare between intrathecal atropine versus preoperative administration of IV ondansetron in decreasing incidence of post operative nausea and vomiting related to intrathecal opioids in post operative period in perineal surgery as regard : efficacy and side effects .

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Age between ( 18 - 45 ) years.
  • Body mass index between ( 18.5 - 35 )
  • patients undergoing perineal surgery as anal fissure , piles and rectocele
  • patients receiving bupivacaine ( 20 mg / 4 ml ) as spinal anesthesia
  • Patinets with physical status 1 or 2 according to ASA classification
Exclusion Criteria
  • Patient refusal .
  • Any contraindication of neuraxial block as : coagulopathy , skin infection at injection site or bacteremia , hypovolemia and shock , history of allergy to L.A , sever aortic stenosis or mitral stenosis ......... etc
  • Patients with physical status other than 1 and 2 according to ASA classification
  • Those with history of nausea and vomiting , also those who received anti emetic drugs in last 2 hours of operation .
  • Allergy to any of the drug included in this study .

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
patients receiving preoperative intravenous ondasetronOndansetron , atropine and bupivacainePatient received intrathecal hyperbaric bupivacaine ( 10 mg ) ( 2 ml 0.5% with 0.5 ml normal saline with morphine 250 mic ) with total volume = 2.5 ml with giving 4 mg IV ondansetron before anesthesia ( patients with body weight more than 80 Kg may need additional 4 mg IV ) .
patients receiving intrathecal atropineOndansetron , atropine and bupivacainePatient received intrathecal hyperbaric bupivacaine ( 10 mg ) ( 2 ml 0.5% ) with morphine 250mic and atropine sulphate 100 micwith total volume = 2.5 ml .
Primary Outcome Measures
NameTimeMethod
frequency of attacks of postoperative nausea and vomiting6-9 months

Intrathecal atropine versus preoperative intravenous ondasetron for prevention of postoperative nausea and vomiting due to intrathecal morphine

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Sohag University Hospital

🇪🇬

Sohag, Egypt

© Copyright 2025. All Rights Reserved by MedPath